Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice Models

The prevalence of non-alcoholic fatty liver disease (NAFLD), which is developed from hepatic steatosis, is increasing worldwide. However, no specific drugs for NAFLD have been approved yet. To observe the effects of Rho, a fraction from Rhodiola crenulate, on non-alcoholic hepatic steatosis, three m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Qin, Sun, Puyang, Li, Juan, Kong, Siming, Tian, Jinying, Li, Xuechen, Yang, Yanan, Zhang, Peicheng, Liu, Yuying, Han, Jingyan, Zhang, Xiaolin, Ye, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861213/
https://www.ncbi.nlm.nih.gov/pubmed/29593573
http://dx.doi.org/10.3389/fphys.2018.00222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861213/
https://www.ncbi.nlm.nih.gov/pubmed/29593573
http://dx.doi.org/10.3389/fphys.2018.00222

Ejemplares similares